Kura Oncology and Kyowa Kirin Report Strong Results from KOMET-007 Trial of Ziftomenib in Newly Diagnosed AML Patients
12/6 13:42
Positive data from KOMET-007 trial shows high remission rates for ziftomenib combined with chemotherapy in AML patients....